XNAS
CAMT
Market cap6.73bUSD
Sep 17, Last price
144.21USD
1D
4.06%
1Q
-26.11%
Jan 2017
4,283.28%
IPO
2,278.53%
Name
Camtek Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Camtek Ltd., along with its affiliated entities, specializes in the development, manufacturing, and distribution of advanced inspection and metrology solutions. These critical tools cater to diverse segments of the semiconductor industry, including advanced interconnect packaging, memory devices, CMOS image sensors, micro-electro-mechanical systems (MEMS), and radio frequency (RF) applications. The company's product lineup features the Eagle-i, an instrument designed for 2D inspection and measurement; the Eagle-AP, a sophisticated platform that integrates software and hardware to provide comprehensive 2D and 3D inspection and metrology capabilities for the advanced packaging sector; and the Golden Eagle, a panel inspection and metrology system specifically engineered for fanout wafer level packaging requirements. Camtek's offerings are available across the Asia Pacific region, the United States, and Europe. Established in 1987, the firm maintains its primary corporate headquarters in Migdal HaEmek, Israel.
Key people
Roy Porat
Chief Executive Officer · since 2010
Moshe Eisenberg
Chief Financial Officer · since 2011
Moshe Grencel
Vice President - Operations · since 2007
Moshe Baruch
Vice President - Research and Development · since 2012
Michael Lev
Vice President - Intellectual Property · since 2007
Boaz Nitzan
Vice President - Digital Material Deposition · since 2012
Amir Tzhori
Vice President - PCB (AOI); General Manager of Camtek China · since 2010
Aharon Sela
Vice President - Sales and President of Camtek Ltd and Camtek Hong Kong · since 2008
Ayelet Peled
Vice President - Human Resources · since 2010
Chairman of the Board · since 2010
Executive Vice President - Business & Strategy and Director · since 2010
Rafi Koriat
External Director · since 2006
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||